Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-life Incidence of Intraocular Inflammation Following Intravitreal Faricimab Therapy

NCT06902207 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT06902207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06902207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-life Incidence of Intraocular Inflammation Following Intravitreal Faricimab Therapy
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Completed
Start date
November 10, 2024
Completion date
March 1, 2025
Enrollment
6,053 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraocular inflammation